| Literature DB >> 22742962 |
Tomomi Harai1, Ran Inoue, Yuko Fujita, Ayumi Tanaka, Mao Horio, Kenji Hashimoto, Kazuhisa Hongou, Toshio Miyawaki, Hisashi Mori.
Abstract
The N-methyl-D-aspartate (NMDA)-type glutamate receptor plays a key role in excitatory synaptic transmission. The overactivation of the NMDA receptor has been implicated in the development of epileptic seizures. D-Serine is a coagonist of the NMDA receptor and its biosynthesis is catalyzed by serine racemase (SR). Here, we examined the effect of d-serine deficiency on the seizures induced by a single injection of pentylenetetrazole (PTZ) using SR knockout (KO) mice. We found that, compared with wild-type (WT) mice, SR-KO mice showed the attenuation of seizure expression in terms of a significantly shortened duration of generalized seizures and resistance to generalized clonic-tonic seizures. Consistently, immunohistochemical analysis of c-Fos demonstrated that the numbers of cells expressing c-Fos induced by high-dose PTZ in the cerebral cortex, hippocampal CA1, hippocampal CA3, and the basolateral nucleus of the amygdala in WT mice were significantly higher than those in SR-KO mice. Moreover, PTZ induced an increase in extracellular glutamate level in the dentate gyrus of WT mice at two different time phases. However, such a PTZ-induced increase in glutamate level was completely inhibited in SR-KO mice. The present findings suggest that SR may be a target for the development of new therapeutic strategies for epileptic seizures.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22742962 DOI: 10.1016/j.eplepsyres.2012.06.001
Source DB: PubMed Journal: Epilepsy Res ISSN: 0920-1211 Impact factor: 3.045